Desarrollo embrionario del pelo (página 5)

Enviado por Villegas Huam�n, Yenner Antonio

Partes: 1, 2, 3, 4, 5

60. Lorenzo EM. Familial
study of hirsutism. J Clin Endocrinol

1970 31:556-564

61. Mahoudeau JA, Bardin
CW, Lipsett MB. The metabolic

clearance rate and origin
of plasma dihydrotestosterone in

man and its conversion to
the 5a-androstenediols. J
Clin

Invest 1971 50:1338-1344

62. Marugo M, Bernasconi D,
Meozzi M, Del Monte P, Zino V,

Primarolo P, Badaracco B.
The use of flutamide in the

management of hirsutism. J
Endocrinol Invest 1994 17:195-199

Revista de Endocrinología
Ginecológica y Reproductiva 17

63. Mathur RS, Moody LO,
Landgrebe S, Williamson HO. Plasma

a n d rogens and sex
hormone binding globulin in the

evaluation of hirsute
females. Fertil Steril 1981 35:29-35

64. Mauvais-Jarvis P.
Regulation of androgen receptor and 5-

reductase in the skin of
normal and hirsute women. Clin

Endocrinol Metab 1986
15:307-317

65. McKenna TJ, Miller RB,
Liddle GW. Plasma pregnenolone

and 17-OH pregnenolone in
patients with adrenal tumors,

ACTH excess, or idiopathic
hirsutism. J Clin Endocrinol

Metab 1977 44:231-236

66. Mehta A, Matwijiw I,
Taylor PJ, Salamon EA, Kredentser JV,

Faiman C. Should androgen
levels be measured in hirsute

women with normal
menstrual cycles? Int J Fertil 1992 37:354-357

67. Meikle AW, Odell WD.
Effect of short and long-term

dexamethasone on
3a-androstanediol glucuronide in hirsute

women. Fertil Steril 1986
46:227-231

68. Mowszowicz I,
Melanitou E, Doukani A, Wright F, Kuttenn F,

Mauvais-Jarvis P. Androgen
binding capacity and 5areductase

activity in pubic skin
fibroblasts from hirsute

patients. J Clin
Endocrinol Metab 1983 56:1209-1213

69. Müderris II, Bayram F,
Sahin Y, Kelestimur F, Tutus A, Ayata

D. The efficacy of 250
mg/day flutamide in the treatment of

patients with hirsutism.
Fertil Steril 1996 66:220-222

70. O"Brien RC, Cooper ME,
Murray RML, Seeman E, Thomas AK,

Jerums G. Comparison of
sequential cypro t e rone acetate/

e s t rogen vs.
spironolactone/oral contraceptive in the tre a t m e n t

of hirsutism. J Clin
Endocrinol Metab 1991 72:1008-1013

71. Oh HS, Smart RC. An
estrogen receptor pathway regulates

the telogen anagen hair
follicle transition and influences

epidermal cell
proliferation. Proc Natl Acad Sci USA 1996

93:12525-12530

72. Pang S, Wang M,
Jeffries S, Riddick L, Clark A, Estrada E.

Normal and elevated
3a-androstanediol glucuro n i d e

concentrations in women
with various causes of hirsutism

and its correlation with
degree of hirsutism and androgen

levels. J Clin Endocrinol
Metab 1992 75:243-48

73. Paoletti A, Cagnacci
A, Orru M, Ajossa S, Guerriero S, Melis

G. Treatment with
flutamide improves hyperinsulinemia in

women with idiopathic
hirsutism. Fertil Steril 1999 72(3):448-453

74. Paoletti AM, Cagnacci
A, Orru M, Ajossa S, Guerriero S, Melis

GB. Treatment with
flutamide improves hyperinsulinemia in

women with idiopathic
hirsutism. Fertil Steril 1999 72:448-453

75. Paulson RJ, Serafini PC,
Catalino JA, Lobo RA. Measurements

of 3a, 17 b-androstanediol
glucuronide in serum and urine

and the correlation with
skin 5a-reductase activity. Fertil

Steril 1996 46:222-226

76. Philpott MP, Sanders
DA, Kealey T. Effects of insulin and

insulin-like growth
factors on cultured human hair follicles:

IGF-1 at physiologic
concentrations is an important regulator of

hair follicle growth in
vitro. J Invest Dermatol 1994 102:857-861

77. Pittaway DE, Maxson
WS, Wentz AC. Spironolactone in

combination drug therapy
for unresponsive hirsutism. Fertil

Steril 1985 43: 878-882

78. Pugeat M, Forest M,
Nisula B, Corniau, De Pere t t i ,

Tourniaire. Evidence of
excessive androgen secretion by

both the ovary and the
adrenal in patients with idiopathic

hirsutism. Obstet Gynecol
1982 59:46-51

79. Randall VA. Androgens
and human hair growth. Clin

Endocrinol 1994 (Oxf)
40:439-457

80. Rittmaster RS,
Thompson DL. Effect of leuprolide and

dexamethasone on hair
growth and hormone levels in

hirsute women: the
relative importance of the ovary and the

adrenal in the
pathogenesis of hirsutism. J Clin Endocrinol

Metab 1990 70:1096-1102

81. Rittmaster RS.
Androgen conjugates: physiology and clinical

significance. Endocr Rev
1993 14:121-132

82. Rittmaster RS.
Finasteride. N Engl J
Med 1994 330:120-125

83. San Millan JL, Sancho J,
Calvo RM. Role of
pentanucleotide

(TTTTA) polymorphism in
the promoter of the CYP11 gene

in the pathogenesis of
hirsutism. Fertil Steril 2001 75(4):797-802

84. Sawaya ME, Price VH.
Different levels of 5 a-reductase type

I and II, aromatase, and
androgen receptor in hair follicles

of women and men with androgenetic
alopecia. J Invest

Dermatol 1997 109:296-300

85. Sawaya ME, Shalita AR.
Androgen receptor polymorphisms

(CAG repeat lengths) in
androgenetic alopecia, hirsutism

and acne. J Cutan Med Surg
1998 3:9-15

86. Serafini P, Lobo RA.
Increased 5a-reductase activity in

idiopathic hirsutism.
Fertil Steril 1985 43:74-78

87. Serafini P, Lobo RA.
The effects of spironolactone on adre n a l

s t e roidogenesis in
hirsute women. Fertil Steril 1985 44:595-599

88. Stenn, Paus, Filippi.
Letter to the Editor. J Invest Dermatol

1998 110:95

8 9 . Tartagni M, Schonauer L, De
Salvia M, Cicinelli E, De

P e rgola G, D"Addario V.
Comparison of Diane 35 and

Diane 35 plus finasteride
in the treatment of hirsutism 2000

7 3 ( 4 ) : 7 1 8 – 7 2 3

90. Thigpen AE, Silver RI,
Guilleyard JM, Casey ML, McConnell

JD, Russell DW. Tissue
distribution and ontogeny of steroid

5-reductase isoenzyme
expression. J Clin Invest 1993 92:903-

910

91. Thomas JP, Oake RJ.
Androgen metabolism in the skin of

hirsute women. J Clin
Endocrinol Metab 1974 38:19-22

92. Tolino A, Petrone A,
Sarnacchiaro F, Cirillo D, Ronsini S,

Lombardi G, Nappi C.
Finasteride in the treatment of

hirsutism: new therapeutic
perspectives. Fertil Steril 1996 66:61-65

93. Venturoli S,
Marescalchi O, Colombo FM, Macrelli S, Ravaioli

B, Bagnoli A, Paradisi R,
Flamigni C. A pro s p e c t i v e

randomized trial comparing
low dose flutamide, finasteride,

ketoconazole, and
cyproterone acetate-estrogen regimens in the treatment of hirsutism. J Clin
Endocrinol Metab 1999 84:1304-1310

94. Vermeulen A, Stoica T,
Verdonck L. The apparent free testosterone concentration, an index of
androgenicity. J Clin

Endocrinol 1971 33:759-767

95. Vottero A, Stratakis
C, Ghizzoni L, Longui C, Karl M, Chrousos G. Androgen Receptor-Mediated
Hypersensitivity

to Androgens in Women with
Nonhyperandro g e n i c

Hirsutism: Skewing of
X-Chromosome Inactivation. J Clin Endocrinol Metab 1999 84(3):1091-1095

96. Wahe M, Antonipillai
I, Horton R. Effects of transforming growth factor band epidermal growth factor
on steroid 5areductase activity in genital skin fibroblasts. Mol Cell Endocrinol
1993 98: 55-59 97. Wilson J 1996 Androgens. In: Gilman AG, Rall TW, Nies AS, Taylor
P (ed) Goodman and Gilman"s The Pharmacological Basis of Therapeutics, ed 9.
McGraw Hill Publishers, New York, pp 1441-1457

98. Wudy S, Wachter U,
Homoki J, Teller W. 5 alpha-androstane- 3 alpha, 17 beta-diol and 5
alpha-andostane-3 alpha, 17 beta-diol-glucuronede in plasma of anormal
children, adults and patients with idiopathic hirsutism: a mass spectrometric study.
Eur J Endocrinol 1996 134(1):87-92

99. Young RL, Goldzieher
JW, Elkind-Hirsch K. The endocrine effects of spironolactone used as an
antiandrogen. Fertil

Steril 1987 48: 223-228